AECLs

AECL stands for Atomic Energy of Canada Limited. It was a Canadian Crown corporation established in 1952, responsible for nuclear research and development. AECL played a significant role in the advancement of nuclear technology, particularly in the design and development of the CANDU reactor. The CANDU, an acronym for CANada Deuterium Uranium, is a Canadian-designed heavy-water moderated, natural uranium fuelled nuclear reactor. This innovative design allowed Canada to export nuclear technology and expertise to several countries.

Beyond reactor design, AECL also conducted research in areas such as nuclear medicine, waste management, and fundamental physics. The corporation was instrumental in the development of radioisotopes used for medical imaging and cancer treatment. AECL operated several research facilities across Canada, including the Chalk River Laboratories, which was a hub for nuclear science. Over its history, AECL underwent several restructuring efforts as governments sought to manage its operations and commercialize its technologies. In 2011, the Canadian government announced plans to privatize AECL's commercial operations, leading to the sale of its reactor division to SNC-Lavalin. The remaining government-owned research and decommissioning portions were eventually integrated into Canadian Nuclear Laboratories.